Correlation Between Axsome Therapeutics and BioCryst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Axsome Therapeutics and BioCryst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axsome Therapeutics and BioCryst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axsome Therapeutics and BioCryst Pharmaceuticals, you can compare the effects of market volatilities on Axsome Therapeutics and BioCryst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axsome Therapeutics with a short position of BioCryst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axsome Therapeutics and BioCryst Pharmaceuticals.
Diversification Opportunities for Axsome Therapeutics and BioCryst Pharmaceuticals
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Axsome and BioCryst is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Therapeutics and BioCryst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioCryst Pharmaceuticals and Axsome Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axsome Therapeutics are associated (or correlated) with BioCryst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioCryst Pharmaceuticals has no effect on the direction of Axsome Therapeutics i.e., Axsome Therapeutics and BioCryst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Axsome Therapeutics and BioCryst Pharmaceuticals
Given the investment horizon of 90 days Axsome Therapeutics is expected to generate 1.33 times more return on investment than BioCryst Pharmaceuticals. However, Axsome Therapeutics is 1.33 times more volatile than BioCryst Pharmaceuticals. It trades about 0.26 of its potential returns per unit of risk. BioCryst Pharmaceuticals is currently generating about 0.05 per unit of risk. If you would invest 8,645 in Axsome Therapeutics on November 4, 2024 and sell it today you would earn a total of 2,001 from holding Axsome Therapeutics or generate 23.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Axsome Therapeutics vs. BioCryst Pharmaceuticals
Performance |
| Timeline |
| Axsome Therapeutics |
| BioCryst Pharmaceuticals |
Axsome Therapeutics and BioCryst Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Axsome Therapeutics and BioCryst Pharmaceuticals
The main advantage of trading using opposite Axsome Therapeutics and BioCryst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axsome Therapeutics position performs unexpectedly, BioCryst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCryst Pharmaceuticals will offset losses from the drop in BioCryst Pharmaceuticals' long position.| Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
| BioCryst Pharmaceuticals vs. TG Therapeutics | BioCryst Pharmaceuticals vs. Axsome Therapeutics | BioCryst Pharmaceuticals vs. Seres Therapeutics | BioCryst Pharmaceuticals vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |